Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Renishaw plc (RNSHF)
Wotton-under-Edge, GB
Renishaw plc is a prominent engineering and scientific technology enterprise based in the United Kingdom. Operating globally, the company specializes in the development, production, sales, distribution, and servicing of a diverse array of metrology and healthcare solutions. Their comprehensive metrology offerings encompass precision measurement and industrial automation tools, including coordinate measuring machines (CMMs), machine tool probes with accompanying software, performance measurement and gauging systems, fixtures, and styli. They also innovate in advanced manufacturing with additive manufacturing systems and both plastics and metal vacuum casting machines, alongside specialized mapping sensors and various encoders (interferometric laser, magnetic, and optical). Within the healthcare sector, Renishaw provides cutting-edge products such as dental scanners, neurosurgical robots with associated accessories and planning software, drug delivery systems, Raman microscopes, bespoke craniomaxillofacial implants, and analytical as well as hybrid Raman systems. Beyond its core technical portfolio, the firm extends its services to include asset financing and even operates a travel agency. Renishaw serves an extensive client base across numerous industries, including aerospace, agriculture, automotive, construction, consumer electronics, energy, power generation, resource exploration, heavy industry, precision manufacturing, and the broader scientific, research, and medical fields. Established in 1973, Renishaw plc maintains its headquarters in Wotton-under-Edge, UK.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +14.72% | +36.16% | +66.83% | +48.87% | +135.19% | +54.86% | -19.49% | +151.32% | +370.70% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
-
Revenue growth Industrial - Machinery: +7.4%+3.2% Q4'25: +10.6% (vs Q4'23)
-
EPS growth Industrial - Machinery: +15.6%-13.5% Q4'25: -19.4% (vs Q4'23)
-
FCF margin FCF growth · Industrial - Machinery: +38.2%+9.6% Q4'25: +5.2% (vs Q4'23)
-
EBIT margin Industrial - Machinery: +10.0%+15.5% ★ Q4'25: +10.1% (vs Q4'23)
-
ROIC Industrial - Machinery: +6.8%+11.7% ★ Q4'25: +18.2% (vs Q4'23)
-
Share dilution Industrial - Machinery: +0.0%+0.0% Q4'25: +0.1% (vs Q4'23)
-
Debt / EBITDA Net debt/EBITDA · Industrial - Machinery: -0.65×0.12× ★ Q4'25: 0.07× (vs Q4'23)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Jun 2015 actual |
Jun 2016 actual |
Jun 2017 actual |
Jun 2018 actual |
Jun 2019 actual |
Jun 2020 actual |
Jun 2021 actual |
Jun 2022 actual |
Jun 2023 actual |
Jun 2024 actual |
Jun 2025 actual |
Jun 2026 3 Rev. Ana. 1 EPS Ana. |
Jun 2027 7 Rev. Ana. 1 EPS Ana. |
Jun 2028 5 Rev. Ana. 1 EPS Ana. |
Jun 2029 3 Rev. Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
494.72M
est: 778.50M (-36.5%)
|
427.22M
est: 567.63M (-24.7%)
|
536.81M
est: 688.03M (-22.0%)
|
611.51M
est: 798.63M (-23.4%)
|
573.96M
est: 747.35M (-23.2%)
|
509.48M
est: 619.18M (-17.7%)
|
567.44M
est: 769.12M (-26.2%)
|
673.70M
est: 812.04M (-17.0%)
|
688.57M
est: 874.34M (-21.2%)
|
691.30M
est: 680.58M (+1.6%)
|
713.04M
est: 710.30M (+0.4%)
|
767.69M
747.67M – 783.89M
+8.1% YoY
|
817.61M
753.89M – 866.86M
+6.5% YoY
|
866.19M
843.60M – 884.47M
+5.9% YoY
|
857.35M
835.00M – 875.45M
-1.0% YoY
|
| EBITDA |
173.74M
est: 196.08M (-11.4%)
|
101.92M
est: 142.97M (-28.7%)
|
153.02M
est: 173.30M (-11.7%)
|
187.17M
est: 201.15M (-7.0%)
|
134.43M
est: 188.24M (-28.6%)
|
54.47M
est: 155.95M (-65.1%)
|
179.77M
est: 193.72M (-7.2%)
|
182.56M
est: 204.53M (-10.7%)
|
177.67M
est: 220.22M (-19.3%)
|
156.07M
est: 171.42M (-9.0%)
|
133.90M
est: 178.91M (-25.2%)
|
193.36M
188.32M – 197.44M
+8.1% YoY
|
205.93M
189.88M – 218.34M
+6.5% YoY
|
218.17M
212.48M – 222.77M
+5.9% YoY
|
215.94M
210.31M – 220.50M
-1.0% YoY
|
| EBIT |
145.69M
est: 157.28M (-7.4%)
|
83.05M
est: 114.68M (-27.6%)
|
119.36M
est: 139.00M (-14.1%)
|
156.81M
est: 161.35M (-2.8%)
|
110.85M
est: 150.99M (-26.6%)
|
5.46M
est: 125.09M (-95.6%)
|
140.77M
est: 155.39M (-9.4%)
|
146.54M
est: 164.06M (-10.7%)
|
145.80M
est: 176.64M (-17.5%)
|
123.24M
est: 137.50M (-10.4%)
|
110.21M
est: 143.50M (-23.2%)
|
155.10M
151.05M – 158.37M
+8.1% YoY
|
165.18M
152.31M – 175.13M
+6.5% YoY
|
175.00M
170.43M – 178.69M
+5.9% YoY
|
173.21M
168.69M – 176.87M
-1.0% YoY
|
| Net Income |
121.91M
est: 180.00M (-32.3%)
|
48.22M
est: 81.25M (-40.6%)
|
88.96M
est: 113.98M (-22.0%)
|
132.92M
est: 161.17M (-17.5%)
|
92.23M
est: 119.62M (-22.9%)
|
288.0K
est: 51.33M (-99.4%)
|
111.46M
est: 132.42M (-15.8%)
|
120.35M
est: 165.31M (-27.2%)
|
116.10M
est: 148.27M (-21.7%)
|
96.89M
est: 101.53M (-4.6%)
|
83.76M
est: 96.33M (-13.1%)
|
118.26M
114.25M – 121.50M
+22.8% YoY
|
131.42M
126.96M – 135.02M
+11.1% YoY
|
145.47M
140.54M – 149.46M
+10.7% YoY
|
—
— – —
-100.0% YoY
|
| SGA |
129.71M
est: 238.27M (-45.6%)
|
135.61M
est: 173.73M (-21.9%)
|
162.85M
est: 210.58M (-22.7%)
|
176.06M
est: 244.43M (-28.0%)
|
183.82M
est: 228.74M (-19.6%)
|
185.98M
est: 189.51M (-1.9%)
|
179.34M
est: 235.40M (-23.8%)
|
192.19M
est: 248.53M (-22.7%)
|
212.48M
est: 267.60M (-20.6%)
|
214.98M
est: 208.30M (+3.2%)
|
220.63M
est: 217.40M (+1.5%)
|
234.96M
228.83M – 239.92M
+8.1% YoY
|
250.24M
230.74M – 265.31M
+6.5% YoY
|
265.11M
258.19M – 270.70M
+5.9% YoY
|
262.40M
255.56M – 267.94M
-1.0% YoY
|
| EPS |
1.68
est: 2.47 (-32.1%)
|
0.66
est: 1.12 (-40.9%)
|
1.22
est: 1.57 (-22.1%)
|
1.83
est: 2.22 (-17.4%)
|
1.27
est: 1.64 (-22.8%)
|
0.00
est: 0.71 (-99.4%)
|
1.53
est: 1.82 (-16.0%)
|
1.65
est: 2.27 (-27.4%)
|
1.60
est: 2.04 (-21.5%)
|
1.33
est: 1.40 (-4.7%)
|
1.15
est: 1.32 (-13.2%)
|
1.63
1.57 – 1.67
+22.8% YoY
|
1.81
1.75 – 1.86
+11.1% YoY
|
2.00
1.93 – 2.05
+10.7% YoY
|
—
— – —
-100.0% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-22 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-18 | A- | 4/5 | 3/5 | 4/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-05-11 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 4/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 3/5 | 3/5 | 4/5 | 3/5 | 2/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Global X Robo Global Robotics and Automation ETF ROBO.AX | 1.25% | 2.69M | 0.69% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| William Lee | Chief Executive Officer & Director | 2M | male |
| Daniel John Deer | Co-Founder & Non-Executive Director | 108.7K | male |
| Clare Nicholls | Group Human Resources Director | — | female |
| Dave Wallace | Director of Group Operations | — | male |
| John Francis Shipsey | CFO & Executive Director | — | male |
| Andy Buttrey | President of APAC | — | — |
| Marc Saunders | Director of Group Strategic Development | — | male |
| Rainer Lotz | President of EMEA | — | male |
| Rob Macdonald | Interim Group Finance Director | — | male |
| Rupert Jones | Managing Director of Renishaw Medical | — | male |
| Kasim Hussain | Group General Counsel & Company Secretary | — | male |
| Chris Pockett | Head of Communications | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for RNSHF
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
